Avantor, Inc. (NYSE:AVTR) Shares Sold by Forsta AP Fonden

Forsta AP Fonden trimmed its stake in Avantor, Inc. (NYSE:AVTR) by 7.6% in the second quarter, HoldingsChannel.com reports. The fund owned 137,300 shares of the company’s stock after selling 11,300 shares during the quarter. Forsta AP Fonden’s holdings in Avantor were worth $2,911,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in AVTR. Versant Capital Management Inc increased its position in Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after buying an additional 1,391 shares in the last quarter. TFO Wealth Partners LLC raised its position in shares of Avantor by 203,100.0% in the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after buying an additional 2,031 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new position in shares of Avantor during the first quarter valued at approximately $93,000. Finally, ORG Partners LLC boosted its position in Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after acquiring an additional 5,773 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on AVTR shares. Morgan Stanley increased their price target on Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Evercore ISI reduced their target price on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 2nd. Citigroup cut Avantor from a “buy” rating to a “neutral” rating and lowered their price target for the company from $30.00 to $23.00 in a report on Wednesday, July 10th. TD Cowen increased their price objective on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Finally, Wells Fargo & Company assumed coverage on shares of Avantor in a report on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 target price for the company. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $27.40.

Avantor Trading Up 1.5 %

Shares of AVTR opened at $26.88 on Monday. Avantor, Inc. has a 12 month low of $16.63 and a 12 month high of $28.00. The stock’s 50-day moving average is $24.42 and its two-hundred day moving average is $24.27. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The stock has a market cap of $18.27 billion, a PE ratio of 68.92, a P/E/G ratio of 2.75 and a beta of 1.32.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Friday, July 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The firm had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. Equities analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.